Monitoring impurities in biopharmaceuticals produced by recombinant technology

Pharmaceutical Science and Technology Today

Volumn 2, Issue 2, 1999, Pages 70-82

  DiPaolo, Byron ^a   Pennetti, Aniello ^a   Nugent, LaDonna ^a   Venkat, Krish ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOXETANE DERIVATIVE; ALKALINE PHOSPHATASE; ANTIGEN; ENDOTOXIN; GUANIDINE; HISTAMINE; HORSERADISH PEROXIDASE; LUMINOL; PROTEIN; PYROGEN;

DEAMINATION; DENATURATION; DNA PROBE; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IMMUNIZATION; IMMUNOASSAY; IMMUNOBLOTTING; LIMULUS LYSATE TEST; MONITORING; NUCLEAR MAGNETIC RESONANCE; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; RECOMBINANT DNA TECHNOLOGY; REVIEW; SPECTROSCOPY; VIRUS;

EID: 0033084068     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00120-0     Document Type: Review

References (103)

1. Anicetti, V.R., Keyt, B.A. and Hancock, W.S. (1989) Trends Biotechnol. 7, 342-349
2. Sofer, G. (1994) BioPharm 7(5), 46-50
3. White, E.M. et al. (1991) BioPharm 4(5), 34-39
4. Thalhamer, J. and Freund, J. (1984) J. Immunol. Methods 66, 245-251
5. Cummings, J.J., Fleischer, E.R. and Federici, M.M. (1987) 1st Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals, 6-8 January, San Francisco, CA, USA (P-306-M)
6. Nugent, L.F. et al. (1998) 2nd Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals, 4-7 January, San Francisco, CA, USA (P-1202-T)
7. Hawkes, R., Niday, E. and Gordon, J. (1982) Anal. Biochem. 119, 142-147
8. Chen, A.B. et al. (1992) Appl. Biochem. Biotechnol. 36, 137-152
9. Briggs, J. et al. (1990) BioTechniques 9, 598-606
10. Ghobrial, I.A., Wong, D.T. and Sharma, B.T. (1997) BioPharm 10(1), 42-45
11. The Center for Biologics Evaluation and Research (1997) Points to Consider in the Manufacture and Testing of Monoclonal Antibodies Products for Human Use Food and Drug Administration, Bethesda, MD, USA
12. Pepin, R.A. et al. (1990) BioTechniques 8, 628-632
13. Per, S.R. et al. (1993) BioPharm 6, 34-40
14. Pollard-Knight, D. et al. (1990) Anal. Biochem. 185, 84-89
15. Ji, X. et al. (1998) 2nd Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals, 4-7 January, San Francisco, CA, USA (P-703-T)
16. Chan, V.T-W., Fleming, K.A. and McGee, J.O'D. (1985) Nucleic Acids Res. 13, 8083-8091
17. Martin, R. et al. (1990) BioTechniques 9, 762-768
18. Harvey, B.M. et al. (1994) in Protocols for Nucleic Acid Analysis by Nonradioactive Probes (Methods in Molecular Biology, Vol. 28) (Isaac, P.G., ed.), pp. 93-100, Humana Press
19. Forster, A.C. et al. (1985) Nucleic Acids Res. 13, 745-761
20. Viscidi, R.P., Connelly, C.J. and Yolken, R.H. (1986) J. Clin. Microbiol. 23, 311-317
21. Riggin, A. et al. (1997) J. Pharm. Biomed. Anal. 16, 561-572
22. Bronstein, I. et al. (1994) in Bioluminescence and Chemiluminescence: Fundamentals and Applied Aspects (Campbell, A.K. et al., eds), pp. 269-272, Wiley
23. Cano, R.J. et al. (1992) BioTechniques 12, 264-268
24. Briggs, J. and Panfili, P. (1991) Anal. Chem. 63, 850-859
25. Singer, V.L. et al. (1997) Anal. Biochem. 249, 228-238
26. Bolger, R. et al. (1997) BioTechniques 23, 532-537
27. Riggin, A., Davis, G.C. and Copmann, T.L. (1996) BioPharm 9, 36-41
28. Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press
29. Ishizawa, M. et al. (1991) Nucleic Acids Res. 19, 5792
30. Workman, W.E. (1995) Pharmacopeial Forum 21, 479-484
31. Hubbard, W.K. (1998) Fed. Regist. 63, 31506-31513
32. Andrews, B.A., Nielsen, S. and Asenjo, J.A. (1996) Bioseparation 6, 303-313
33. Fujii, M. et al. (1996) Int. J. Biochem. Cell Biol. 28, 1381-1391
34. Webster, H.V. et al. (1990) J. Immunol. Methods 134, 95-100
35. MacDonald, M.J. and Gapinski, J.P. (1989) Metabolism 38, 450-452
36. Angel, I. (1988) Experientia 44, 877-879
37. Comitti, R. et al. (1987) J. Immunol. Methods 99, 25-37
38. Hentz, N.G. et al. (1997) Anal. Chem. 69, 4994-5000
39. McComb, M.E. et al. (1998) J. Chromatogr. 800, 1-11
40. Yomota, C. et al. (1997) J. Chromatogr. 703, 139-145
41. Pacakova, V., Suchankova, J. and Stulik, K. (1996) J. Chromatogr. 681, 69-76
42. Lim, H.B., Lee, J.J. and Lee, K.J. (1995) Electrophoresis 16, 674-678
43. Klyushnichenko, V.E. et al. (1994) J. Chromatogr. 661, 83-92
44. Lookabaugh, M., Biswas, M. and Krull, I.S. (1991) J. Chromatogr. 549, 357-366
45. Briggs, J. et al. (1990) BioTechniques 9, 598-660
46. Grimshaw, C. et al. (1997) J. Pharm. Biomed. Anal. 16, 605-612
47. Pennetti, A. (1998) 2nd Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals, 4-7 January, San Francisco, CA, USA (P-1203-T)
48. Mukhopadhyay, A. (1997) Adv. Biochem. Eng. Biotechnol. 56, 61-109
49. Wells, P.A. (1994) Protein Expres. Purif. 5, 391-401
50. Huang, S.M. and Huang, Y.C. (1988) J. Chromatogr. 429, 235-253
51. Boppana, V.K., Rhodes, G.R. and Brooks, D.P. (1990) Anal. Biochem. 184, 213-218
52. Boppana, V.K. and Rhodes, G.R. (1990) J. Chromatogr. 506, 279-288
53. Bielicki, J. et al. (1998) Biochem. J. 329, 145-150
54. Simonsen, C.S., Walter, M. and Levinson, A.D. (1988) Nucleic Acids Res. 16, 2235-2246
55. Najjar, T.A., Matar, K.M. and Alfawaz, I.M. (1992) Ther. Drug Monit. 14, 142-146
56. Cosolo, W., Drummer, O.H. and Christophidis, N. (1989) J. Chromatogr. 494, 201-208
57. Huang, M.M. et al. (1998) 22nd International Symposium on High Performance Liquid Phase Separations and Related Techniques, 2-8 May, St. Louis, MO, USA (P-0250-T)
58. Albertioni, F. et al. (1996) Clin. Chem. 42, 39-44
59. Slordal, L. et al. (1986) Ther. Drug Monit. 8, 368-372
60. Fong, K.L. et al. (1981) Antimicrob. Agents Chemother. 19, 139-143
61. Karkhanis, Y.D. and Schmatz, D.M. (1998) J. Clin. Microbiol. 36, 1414-1418
62. Oeltgen, P.R. et al. (1984) Ther. Drug Monit. 6, 360-367
63. Kurtz, M.J. et al. (1983) Clin. Chem. 29, 1015-1019
64. Woo, J., Longley, M.A. and Cannon, D.C. (1982) Clin. Chem. 28, 1370-1374
65. Schwenzer, K.S., Wang, C.H. and Anhalt, J.P. (1983) Ther. Drug Monit. 5, 341-345
66. Uematsu, T. et al. (1988) Ther. Drug Monit. 10, 459-462
67. Brillhart, K.L. et al. (1996) Clin. Chem. 42, S-214
68. Awni, W.M. et al. (1991) Ther. Drug Monit. 13, 511-517
69. Straub, R.F. and Voyksner, R.D. (1993) J. Chromatogr. 647, 167-181
70. Holt, D.E. et al. (1990) J. Antimicrob. Chemother. 26, 107-115
71. Liang, P., Sanchez, R.I. and Martin, M.T. (1996) Anal. Chem. 68, 2426-2431
72. Lillehoj, E.P. and Malik, V.S. (1989) Adv. Biochem. Eng. Biotechnol. 40, 44-52
73. Ransohoff, T.C. and Levine, H.L. (1991) in Purification and Analysis of Recombinant Proteins (Seetharam, R. and Sharma, S.K., eds), pp. 223-227, Marcel Dekker
74. Banck, G. and Forsgren, A. (1978) Scand. J. Immunol. 8, 347-355
75. Nardella, F.A. et al. (1988) Scand. J. Rheumatol. Suppl. 75, 190-198
76. Godfrey, M.A. et al. (1992) J. Immunol. Methods 149, 21-27
77. Considine, P.J., Duggan, P and Eadie, A. (1986) Biosci. Rep. 6, 933-936
78. Chen, T. (1992) Drug Dev. Ind. Pharm. 18, 1311-1354
79. Manning, M.C., Patel, K. and Borchardt, R.T. (1989) Pharm. Res. 6, 903-918
80. van Nispen, J.W (1987) in Topics in Pharmaceutical Sciences (Briemer, D.D. and Speiser, P., eds), pp. 293-307, Elsevier Science
81. Geigert, J. (1989) J. Parenter. Sci. Technol. 43, 220-224
82. Cleland, J.L., Powell, M.F. and Shire, S.J. (1993) Crit. Rev. Ther. Drug Carrier Syst. 10, 307-377
83. Wright, A. and Morrison, S.L. (1997) Trends Biotechnol. 15, 26-32
84. Aswad, D.W. and Guzzetta, A.W. (1995) in Deamidation and Isoaspartate Formation in Peptides and Proteins (Aswad, D.W., ed.), pp. 7-29, CRC Press
85. Bongers, J. et al. (1992) Int. J. Pept. Protein Res. 39, 364-374
86. Wright, H.T. (1991) Crit. Rev. Biochem. Mol. Biol. 26, 1
87. Chazin, W.J. and Kossiakoff, A.A. (1995) in Deamidation and Isoaspartate Formation in Peptides and Proteins (Aswad, D.W., ed.), pp. 193-206, CRC Press
88. Wong, D. and Parasrampuria, J. (1997) BioPharm 10(11), 52-61
89. Nguyen, T.H. (1994) in Formulation and Delivery of Proteins and Peptides, pp. 59-62, 69, American Chemical Society
90. Wang, Y.J. and Hanson, M.A. (1988) J. Parenter. Sci. Technol. 42, S4-S24
91. Lindner, H. et al. (1996) J. Chromatogr. A 743, 137-144
92. Kenney, W.C. et al. (1986) Lymph. Res. 5 (Suppl. 1), S23-S27
93. Townsend, R.R. (1993) Am. Chem. Soc. Symp. 86-101
94. Anumula, K. (1997) in Techniques in Glycobiology (Townsend, R. and Hotchkiss, A.T. Jr, eds), pp. 349-357, Marcel Dekker
95. Jones, A.J.S. (1993) Adv. Drug Deliv. Rev. 10, 29-90
96. Huhmer, A.F.R. et al. (1997) Anal. Chem. 69, 29R-57R
97. ™ Protein Deamidation Detection Kit Insert, Product TB1001, Printed 4/95, Promega Corp., Madison, WI, USA
98. Federici, M.M. (1994) Biologicals 22, 151-159
99. Colby, C.B. et al. (1984) J. Immunol. 133, 3091-3095
100. Proudnikov, D. et al. (1998) Anal. Biochem. 259, 34-41
101. Thorp, H.H. (1998) Trends Biotechnol. 16, 117-121
102. DeFrutos, M. and Regnier, F.E. (1993) Anal. Chem. 65, 17A-25A
103. Shimura, K. and Karger, B.L. (1994) Anal. Chem. 66, 9